Bristol-Myers Squibb Company
PET imaging with PD-L1 binding polypeptides
Last updated:
Abstract:
Provided herein are novel .sup.10Fn3 domains which specifically bind to PD-L1, as well as imaging agents based on the same for diagnostics.
Status:
Grant
Type:
Utility
Filling date:
31 May 2017
Issue date:
31 May 2022